Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Colorcon
Express Scripts
McKesson
Baxter

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR AVODART


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Avodart

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00161421 ↗ Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 2 2005-03-01 The purpose of this study is to test the how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future. We will be administering three drugs. Dutasteride is FDA approved to treat prostate enlargement. Lupron is approved for treatment of prostate cancer. Testosterone is approved for treatment of testicular insufficiency. They are being used in this study for "off-label" research purposes. This study will allow us to find out the effect of food on two formulations of testosterone taken by mouth, and the relative effect of food on testosterone absorption. Information from this study may be useful in treatment of men with low testosterone levels and the development of a male hormonal contraceptive.
NCT00161421 ↗ Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone Completed GlaxoSmithKline Phase 2 2005-03-01 The purpose of this study is to test the how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future. We will be administering three drugs. Dutasteride is FDA approved to treat prostate enlargement. Lupron is approved for treatment of prostate cancer. Testosterone is approved for treatment of testicular insufficiency. They are being used in this study for "off-label" research purposes. This study will allow us to find out the effect of food on two formulations of testosterone taken by mouth, and the relative effect of food on testosterone absorption. Information from this study may be useful in treatment of men with low testosterone levels and the development of a male hormonal contraceptive.
NCT00161421 ↗ Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone Completed National Institutes of Health (NIH) Phase 2 2005-03-01 The purpose of this study is to test the how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future. We will be administering three drugs. Dutasteride is FDA approved to treat prostate enlargement. Lupron is approved for treatment of prostate cancer. Testosterone is approved for treatment of testicular insufficiency. They are being used in this study for "off-label" research purposes. This study will allow us to find out the effect of food on two formulations of testosterone taken by mouth, and the relative effect of food on testosterone absorption. Information from this study may be useful in treatment of men with low testosterone levels and the development of a male hormonal contraceptive.
NCT00161421 ↗ Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone Completed University of Washington Phase 2 2005-03-01 The purpose of this study is to test the how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future. We will be administering three drugs. Dutasteride is FDA approved to treat prostate enlargement. Lupron is approved for treatment of prostate cancer. Testosterone is approved for treatment of testicular insufficiency. They are being used in this study for "off-label" research purposes. This study will allow us to find out the effect of food on two formulations of testosterone taken by mouth, and the relative effect of food on testosterone absorption. Information from this study may be useful in treatment of men with low testosterone levels and the development of a male hormonal contraceptive.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Avodart

Condition Name

Condition Name for Avodart
Intervention Trials
Prostate Cancer 11
Prostatic Hyperplasia 6
Benign Prostatic Hyperplasia 5
Alcohol Abuse 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Avodart
Intervention Trials
Prostatic Neoplasms 13
Prostatic Hyperplasia 12
Hyperplasia 10
Alcoholism 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Avodart

Trials by Country

Trials by Country for Avodart
Location Trials
United States 56
Germany 10
Korea, Republic of 6
United Kingdom 6
Canada 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Avodart
Location Trials
Washington 7
Connecticut 6
Massachusetts 6
Illinois 3
Ohio 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Avodart

Clinical Trial Phase

Clinical Trial Phase for Avodart
Clinical Trial Phase Trials
Phase 4 7
Phase 3 2
Phase 2/Phase 3 2
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Avodart
Clinical Trial Phase Trials
Completed 29
Withdrawn 2
Terminated 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Avodart

Sponsor Name

Sponsor Name for Avodart
Sponsor Trials
GlaxoSmithKline 17
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 5
University of Washington 5
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Avodart
Sponsor Trials
Other 35
Industry 20
NIH 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Boehringer Ingelheim
Merck
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.